- Home
- ALLE vs DVA Comparison
ALLE vs DVA Comparison
Compare ALLE & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLE
- DVA
- Stock Information
- Founded
- ALLE 2013
- DVA 1994
- Country
- ALLE Ireland
- DVA United States
- Employees
- ALLE N/A
- DVA N/A
- Industry
- ALLE Diversified Commercial Services
- DVA Misc Health and Biotechnology Services
- Sector
- ALLE Consumer Discretionary
- DVA Health Care
- Exchange
- ALLE Nasdaq
- DVA Nasdaq
- Market Cap
- ALLE 12.3B
- DVA 10.9B
- IPO Year
- ALLE N/A
- DVA 1995
- Fundamental
- Price
- ALLE $142.68
- DVA $136.18
- Analyst Decision
- ALLE Hold
- DVA Hold
- Analyst Count
- ALLE 5
- DVA 4
- Target Price
- ALLE $140.40
- DVA $157.00
- AVG Volume (30 Days)
- ALLE 869.0K
- DVA 828.5K
- Earning Date
- ALLE 07-23-2025
- DVA 05-12-2025
- Dividend Yield
- ALLE 1.43%
- DVA N/A
- EPS Growth
- ALLE 16.19
- DVA 14.90
- EPS
- ALLE 7.12
- DVA 10.11
- Revenue
- ALLE $3,820,200,000.00
- DVA $12,968,524,000.00
- Revenue This Year
- ALLE $6.04
- DVA $6.00
- Revenue Next Year
- ALLE $4.65
- DVA $3.66
- P/E Ratio
- ALLE $20.03
- DVA $13.48
- Revenue Growth
- ALLE 5.48
- DVA 5.11
- 52 Week Low
- ALLE $113.27
- DVA $131.76
- 52 Week High
- ALLE $156.10
- DVA $179.60
- Technical
- Relative Strength Index (RSI)
- ALLE 57.18
- DVA 37.73
- Support Level
- ALLE $140.16
- DVA $136.50
- Resistance Level
- ALLE $144.80
- DVA $140.42
- Average True Range (ATR)
- ALLE 2.23
- DVA 3.66
- MACD
- ALLE -0.51
- DVA -0.59
- Stochastic Oscillator
- ALLE 43.60
- DVA 11.71
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.